Novavax (NVAX) closed the most recent trading day at $179.14, moving +0.75% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.33%.Prior to today's trading, shares of the vaccine maker had gained 0.89% over the past month. This has outpaced the Medical sector's loss of 4.76% and lagged the S&P 500's gain of 2.89% in that time.NVAX will be looking to display strength as it nears its next earnings release, which is expected to be August 5, 2021. The company is expected to report EPS of -$3.76, down 1153.33% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $370.8 million, up 943.33% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$6.42 per share and revenue of $1.94 billion. These totals would mark changes of +11.69% and +308.28%, respectively, from last year.Investors should also note any recent changes to analyst estimates for NVAX. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. NVAX is holding a Zacks Rank of #5 (Strong Sell) right now.The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 199, putting it in the bottom 22% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Bitcoin, Like the Internet Itself, Could Change Everything Blockchain and cryptocurrency has sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree we’re still in the early stages of this technology, and as it grows, it will create several investing opportunities. Zacks’ has just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them directly. See 3 crypto-related stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Novavax, Inc. (NVAX): Free Stock Analysis Report To read this article on Zacks.com click here.